ETPrime

Sequent Scientific - Viyash Scientific Share Price

  • 249.950.75 (0.31%)
  • Volume: 23,76,512
  • Closed
  • Last Updated On: 12 Jun, 2026, 03:57 PM IST
STOCK SCORE
ETPrime Only
High: "310.00",Open: "300.00",Low: "290.00",
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Sequent Scientific - Viyash Scientific Share Price
  • 249.950.75 (0.31%)
  • Volume: 23,76,512
Advertisment

Key Metrics

PE Ratio
(x)		91.30
EPS - TTM
(₹)		2.74
MCap
(₹ Cr.)		10,919.09
Sectoral MCap Rank
43
PB Ratio
(x)		3.54
Div Yield
(%)		0.00
Face Value
(₹)		2.00
Beta

Beta

1 Month1.03
3 Months0.93
6 Months1.16
1 Year1.39
3 Years1.45

1.03
VWAP
(₹)		251.31
52W H/L
(₹)
277.35 / 166.00

Sequent Scientific share price insights

  • Company's annual revenue growth of 121.18% outperformed its 3 year CAGR of 33.99%. (Source: Consolidated Financials)

  • Company has spent 2.02% of its operating revenues towards interest expenses and 16.53% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

  • Viyash Scientific Ltd. share price moved up by 0.31% from its previous close of Rs 249.20. Viyash Scientific Ltd. stock last traded price is 249.95

    Share PriceValue
    Today/Current/Last249.95
    Previous Day249.20249.35

InsightsSequent Scientific

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Sequent Scientific Share Price Returns

    1 Day0.31%
    1 Week-2.08%
    1 Month16.42%
    3 Months27.49%
    1 Year28.44%
    3 Years222.52%
    5 Years-8.07%

    ET Stock ScreenersTop Score Companies

    Check whether Sequent Scientific belongs to analysts' top-rated companies list?

    View Stock Screeners

    News & Analysis

    View all Sequent Scientific Share News & Announcements

    Sequent Scientific Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Share Recommendations

    Recent Recos

    STRONG BUY

    Current

    Mean Recos by 2 Analysts

    Strong
    Sell    SellHoldBuyStrong
    Buy
    • Target₹130
    • OrganizationYes Securities
    • BUY
    • Target₹145
    • OrganizationHDFC Securities
    • BUY

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy2221
    Buy----
    Hold----
    Sell----
    Strong Sell----
    # Analysts2221
    View all Stock Recommendations

    Financials

    • Insights

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 121.18% outperformed its 3 year CAGR of 33.99%. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent 2.02% of its operating revenues towards interest expenses and 16.53% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
      Quarterly | AnnualDec 2025Sep 2025Jun 2025Mar 2025Dec 2024
      Total Income872.39426.14445.29403.36396.65
      Total Income Growth (%)104.72-4.3010.401.696.29
      Total Expenses782.57385.47405.61371.92373.60
      Total Expenses Growth (%)103.02-4.979.06-0.456.45
      EBIT89.8240.6739.6831.4423.05
      EBIT Growth (%)120.852.4926.2136.403.88
      Profit after Tax (PAT)38.4414.7414.319.326.48
      PAT Growth (%)160.793.0053.5443.832.21
      EBIT Margin (%)10.309.548.917.795.81
      Net Profit Margin (%)4.413.463.212.311.63
      Basic EPS (₹)0.890.590.570.370.14
      Quarterly | AnnualDec 2025Sep 2025Jun 2025Mar 2025Dec 2024
      Total Income357.9345.7852.5554.6048.15
      Total Income Growth (%)681.85-12.88-3.7513.40-16.90
      Total Expenses343.7640.6146.6947.7043.30
      Total Expenses Growth (%)746.49-13.02-2.1210.16-14.31
      EBIT14.175.175.866.904.85
      EBIT Growth (%)174.08-11.77-15.0742.27-34.55
      Profit after Tax (PAT)-0.083.083.374.232.81
      PAT Growth (%)-102.60-8.61-20.3350.53-34.04
      EBIT Margin (%)3.9611.2911.1512.6410.07
      Net Profit Margin (%)-0.026.736.417.755.84
      Basic EPS (₹)0.000.120.140.170.11
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue1,566.061,380.691,427.301,423.661,369.98
      Total Revenue Growth (%)13.43-3.270.263.9215.19
      Total Expenses1,516.771,417.941,500.161,370.281,224.53
      Total Expenses Growth (%)6.97-5.489.4811.9011.80
      Profit after Tax (PAT)21.88-35.87-121.1641.2595.44
      PAT Growth (%)---393.71-56.7836.53
      Operating Profit Margin (%)7.090.79-2.624.8912.47
      Net Profit Margin (%)1.41-2.61-8.522.917.00
      Basic EPS (₹)0.88-1.44-4.881.673.87
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue229.19214.50250.93247.27285.42
      Total Revenue Growth (%)6.85-14.521.48-13.3718.00
      Total Expenses202.27208.48260.67231.58241.98
      Total Expenses Growth (%)-2.98-20.0212.56-4.3010.45
      Profit after Tax (PAT)15.790.62-6.0814.8032.11
      PAT Growth (%)2,439.23--141.08-53.9250.48
      Operating Profit Margin (%)17.326.15-3.247.8717.37
      Net Profit Margin (%)8.860.36-2.736.7312.09
      Basic EPS (₹)0.630.03-0.240.601.30

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets1,601.951,540.381,529.121,441.501,392.56
      Total Assets Growth (%)4.000.746.083.51-8.28
      Total Liabilities831.58827.43779.93701.08616.24
      Total Liabilities Growth (%)0.506.0911.2513.77-15.68
      Total Equity770.36712.96749.19740.41776.32
      Total Equity Growth (%)8.05-4.841.19-4.62-1.42
      Current Ratio (x)1.731.311.501.541.55
      Total Debt to Equity (x)0.630.690.570.460.27
      Contingent Liabilities559.95588.21184.31223.526.26
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets1,222.201,187.601,122.771,124.231,102.12
      Total Assets Growth (%)2.915.77-0.132.0110.50
      Total Liabilities79.55100.3764.4183.1472.61
      Total Liabilities Growth (%)-20.7455.83-22.5314.50-34.67
      Total Equity1,142.651,087.231,058.361,041.091,029.51
      Total Equity Growth (%)5.102.731.661.1216.17
      Current Ratio (x)1.421.071.381.811.69
      Total Debt to Equity (x)0.040.040.020.020.01
      Contingent Liabilities515.57284.45266.31247.440.99

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 84.12 cr for investing activities which is an YoY increase of 239.49%. (Source: Consolidated Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities83.3630.6016.8130.60114.75
      Net Cash used in Investing Activities-24.78-5.92-64.96-95.579.65
      Net Cash flow from Financing Activities-60.73-1.4432.2367.26-138.75
      Net Cash Flow-2.1523.24-15.923.75-14.35
      Closing Cash & Cash Equivalent62.6664.8141.5757.5053.74
      Closing Cash & Cash Equivalent Growth (%)-3.3255.89-27.696.98-21.08
      Total Debt/ CFO (x)5.3514.7523.6710.291.71
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities-1.13-26.9437.759.362.34
      Net Cash used in Investing Activities-0.445.47-50.70-4.25170.00
      Net Cash flow from Financing Activities0.6722.320.247.25-174.78
      Net Cash Flow-0.900.84-12.7112.36-2.44
      Closing Cash & Cash Equivalent0.030.930.0812.800.44
      Closing Cash & Cash Equivalent Growth (%)-96.761,015.66-99.352,841.61-84.86
      Total Debt/ CFO (x)-39.45-1.720.511.662.23

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)3.10-5.46-17.336.0313.11
      Return on Capital Employed (%)10.031.18-3.727.4418.22
      Return on Assets (%)1.36-2.32-7.922.866.85
      Interest Coverage Ratio (x)2.911.510.527.626.97
      Asset Turnover Ratio (x)0.990.890.170.1797.77
      Price to Earnings (x)151.52-80.65-14.9580.6562.89
      Price to Book (x)4.654.382.594.868.22
      EV/EBITDA (x)21.0645.79120.8630.1628.00
      EBITDA Margin (%)11.375.281.298.5116.18
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)1.380.05-0.571.433.11
      Return on Capital Employed (%)2.690.95-0.681.654.47
      Return on Assets (%)1.290.05-0.541.312.91
      Interest Coverage Ratio (x)9.994.430.7516.7017.21
      Asset Turnover Ratio (x)0.150.150.200.2024.08
      Price to Earnings (x)208.335,000.00-303.03227.27188.68
      Price to Book (x)2.872.651.713.225.81
      EV/EBITDA (x)83.88151.24972.14123.67108.36
      EBITDA Margin (%)22.1811.460.8412.2420.81

    Sequent Scientific

    • Income (P&L)
    • Cash Flow

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 121.18% outperformed its 3 year CAGR of 33.99%. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent 2.02% of its operating revenues towards interest expenses and 16.53% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

      • Increase in Cash from Investing

        Company has used Rs 84.12 cr for investing activities which is an YoY increase of 239.49%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Share Price Forecast

    • Get multiple analysts’ prediction on Sequent Scientific

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Sequent Scientific

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Sequent Scientific

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Peer Comparison

    Sequent Scientific

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Shareholding Pattern

      • Loading...
        Showing Sequent Scientific Shareholding as on Mar 2026
        CategoryMar 2026Dec 2025Sep 2025Jun 2025
        Promoters61.3161.4152.3352.61
        Pledge0.000.000.000.00
        FII2.943.155.906.15
        DII7.987.3612.9112.98
        Mutual Funds6.445.8210.0410.08
        Others27.7628.0828.8628.26
      • Showing Shareholding as on Mar 2026
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters26,78,40,33461.31 %-0.09
        Pledge00.00 %0.00
        FII1,28,50,1452.94 %-0.21
        DII3,48,88,5667.98 %0.62
        MF2,81,51,6326.44 %0.62
        Others12,12,71,76527.76 %-0.31

      MF Ownership

      MF Ownership as on 30 April 2026

      View all Mutual Fund Schemes
      Top Searches:
      Sequent Scientific News Sequent Scientific Quarterly Results Sequent Scientific Dividend Sequent Scientific Q1 ResultsSequent Scientific Q2 ResultsSequent Scientific Q3 ResultsSequent Scientific Q4 Results

      Corporate Actions

      • Meeting DateAnnounced onPurposeDetails
        Jun 30, 2026Jun 01, 2026POM-
        May 19, 2026May 12, 2026Board MeetingAudited Results & Final Dividend
        Mar 14, 2026Feb 10, 2026POM-
        Feb 05, 2026Jan 21, 2026Board MeetingQuarterly Results
        Dec 30, 2025Nov 28, 2025POM-
      • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
        Final25%0.5Sep 08, 2021Jul 01, 2021
        Final10%0.2Aug 21, 2019May 14, 2019
        Interim10%0.2Nov 20, 2017Nov 09, 2017
        Final 15%1.5Sep 16, 2011May 30, 2011
        Final 20%2.0Sep 23, 2010May 31, 2010
      • All TypesEx-DateRecord DateAnnounced onDetails
        SplitsFeb 25, 2016Feb 26, 2016Oct 29, 2015Split: Old FV10.0| New FV:2.0

      About Sequent Scientific

      Viyash Scientific Ltd., incorporated in the year 1985, is a Small Cap company (having a market cap of Rs 10,919.09 Crore) operating in Pharmaceuticals sector. Viyash Scientific Ltd. key Products/Revenue Segments include Bulk Drugs, Processing & Conversion Charges, Duty Drawback, Scrap, Other Operating Revenue for the year ending 31-Mar-2025. Show More

      • Executives

      • Auditors

      • KK

        Kamal K Sharma

        Chairman & Ind.Director
        RN

        Rajaram Narayanan

        Managing Director & CEO
        VR

        Vedprakash Ragate

        Executive Director
        FK

        Fabian Kausche

        Non Executive Director
        Show More
      • S R B C & Co. LLP

      Industry

      Pharma - Indian

      Key Indices Listed on

      BSE SmallCap, BSE Healthcare, BSE AllCap, + 7 more

      Address

      3rd Floor, Srivalli�s Corporate,Plot No. 290, SYN 33 34P TO 39,Hyderabad, Telangana - 500033

      Contact

      investorrelations@sequent.in

      http://www.sequent.in

      More Details

      FAQs about Sequent Scientific share

      • 1. What is Sequent Scientific share price and what are the returns for Sequent Scientific share?
        As on 12 Jun, 2026, 03:59 PM IST Sequent Scientific share price is up by 0.31% basis the previous closing price of Rs 252.3. Sequent Scientific share price is Rs 249.95. Return Performance of Sequent Scientific Shares:
        • 1 Week: Sequent Scientific share price moved down by 2.08%
      • 2. What are the returns for Sequent Scientific share?
        Return Performance of Sequent Scientific Shares:
        • 1 Week: Sequent Scientific share price moved down by 2.08%
      • 3. What is the PE & PB ratio of Sequent Scientific?
        The PE ratio of Sequent Scientific stands at 91.02, while the PB ratio is 3.5.
      • 4. What is 52 week high/low of Sequent Scientific share price?
        In last 52 weeks Sequent Scientific share had a high price of Rs 277.35 and low price of Rs 166.00
      • 5. What's the market capitalization of Sequent Scientific?
        Sequent Scientific share has a market capitalization of Rs 10,919.09 Cr. Within Pharmaceuticals sector, it's market cap rank is 43.

      Trending in Markets

      Top Gainers As on 04:06 PM | 12 Jun 2026

      IFCI84.57
      14.09 (20.00%)
      Authum Investment530.15
      70.20 (15.27%)
      Tata Teleservices46.44
      4.29 (10.18%)
      Ashok Leyland152.45
      13.87 (10.01%)
      Netweb Technologies4,587.40
      396.00 (9.45%)

      Top Losers As on 03:58 PM | 12 Jun 2026

      Nestle India1,375.70
      -46.80 (-3.29%)
      Oil India Ltd417.80
      -11.56 (-2.70%)
      ONGC246.20
      -6.41 (-2.54%)
      Tech Mahindra1,429.20
      -35.90 (-2.46%)
      OneSource Specialty1,612.50
      -38.91 (-2.36%)

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      Business News›Markets›Stocks›Stock Price Quotes›Sequent Scientific Share Price
      The Economic Times
      BrowseCompanies: